|
Twelve months ended |
|
October 31, 2021 | |
October 31, 2020 |
Cash flows from operating activities: | | | |
Net earnings | $ | 6,503 | | | $ | 2,844 | |
Adjustments to reconcile net earnings to net cash provided by operating activities: | | | |
Depreciation and amortization | 785 | | | 789 | |
Stock-based compensation expense | 330 | | | 278 | |
Restructuring and other charges | 245 | | | 462 | |
Deferred taxes on earnings | (605 | ) | | 70 | |
Defined benefit plan settlement (gains) charges | (37 | ) | | 214 | |
Other, net | 440 | | | 325 | |
Changes in operating assets and liabilities, net of acquisitions: | | | |
Accounts receivable | (80 | ) | | 575 | |
Inventory | (2,164 | ) | | (386 | ) |
Accounts payable | 1,257 | | | (35 | ) |
Net investment in leases | (111 | ) | | (152 | ) |
Taxes on earnings | 64 | | | (147 | ) |
Restructuring and other | (205 | ) | | (489 | ) |
Other assets and liabilities | (13 | ) | | (32 | ) |
Net cash provided by operating activities | 6,409 | | | 4,316 | |
Cash flows from investing activities: | | | |
Investment in property, plant and equipment | (582 | ) | | (580 | ) |
Proceeds from the sale of property, plant and equipment | — | | | 3 | |
Purchases of available-for-sale securities and other investments | (28 | ) | | (693 | ) |
Maturities and sales of available-for-sale securities and other investments | 304 | | | 417 | |
Collateral posted for derivative instruments | 148 | | | (163 | ) |
Payment made in connection with business acquisitions, net of cash acquired | (854 | ) | | — | |
Net cash used in investing activities | (1,012 | ) | | (1,016 | ) |
Cash flows from financing activities: | | | |
Proceeds from short-term borrowings with original maturities less than 90 days, net | 400 | | | — | |
Proceed from short-term borrowings with original maturities greater than 90 days | 22 | | | 27 | |
Proceeds from debt, net of issuance costs | 2,099 | | | 3,081 | |
Payment of debt | (1,245 | ) | | (1,849 | ) |
Stock-based award activities and others | (51 | ) | | (128 | ) |
Repurchase of common stock | (6,249 | ) | | (3,107 | ) |
Cash dividends paid | (938 | ) | | (997 | ) |
Net cash used in financing activities | (5,962 | ) | | (2,973 | ) |
(Decrease) increase in cash and cash equivalent | (565 | ) | | 327 | |
Cash and cash equivalents at beginning of period | 4,864 | | | 4,537 | |
Cash and cash equivalents at end of period | $ | 4,299 | | | $ | 4,864 | |